Back to Florida

SB1752 • 2026

Suicide and Drug Overdose Prevention

Suicide and Drug Overdose Prevention

Healthcare
Passed Legislature

This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.

Sponsor
DiCeglie
Last action
2026-03-13
Official status
Senate - Died in Children, Families, and Elder Affairs
Effective date
2026-07-01

Plain English Breakdown

The bill did not pass all stages of the legislative process and is therefore not currently law.

Suicide and Drug Overdose Prevention

This act establishes committees within the Department of Health to review drug overdose deaths and suicide cases for prevention strategies.

What This Bill Does

  • Creates the Drug Overdose Death Review Committee within the Department of Health to study drug-related deaths.
  • Establishes local review committees in each area to look at individual drug overdose death cases.
  • Sets up a Suicide Death Review Committee to examine suicide cases and suggest ways to prevent them.
  • Requires these committees to submit annual reports with their findings to help improve policies and services.

Who It Names or Affects

  • People who die from drug overdoses or suicide in Florida.
  • Healthcare providers and local public health departments that must participate in the review process.
  • The Department of Health which will oversee these committees.

Terms To Know

Drug Overdose Death Review Committee
A group within the Florida Department of Health that studies drug-related deaths to find ways to prevent them.
Suicide Death Review Committee
A committee set up by the state to look into suicide cases and recommend prevention strategies.

Limits and Unknowns

  • The bill did not pass all stages of review in the legislature.
  • It is unclear how much funding will be available for these committees.

Bill History

  1. 2026-03-13 Senate

    • Died in Children, Families, and Elder Affairs

  2. 2026-01-22 Senate

    • Introduced

  3. 2026-01-16 Senate

    • Referred to Children, Families, and Elder Affairs; Appropriations Committee on Health and Human Services; Fiscal Policy

  4. 2026-01-09 Senate

    • Filed

Official Summary Text

Suicide and Drug Overdose Prevention; Creating the Drug Overdose Death Review Committee and the Suicide Death Review Committee, respectively, within the Department of Health for specified purposes; providing for membership of the committees and duties of the Drug Overdose Death Review Committee and the Suicide Death Review Committee, respectively; authorizing external stakeholders to review specified information; requiring the Drug Overdose Death Review Committee and the Suicide Death Review Committee, respectively, to annually submit a report to the Department of Health and the Statewide Drug Policy Advisory Council by a specified date, etc.

Current Bill Text

Read the full stored bill text
Florida Senate
-
2026

SB 1752

By
Senator DiCeglie

18-00921C-26 20261752__
1 A bill to be entitled
2 An act relating to suicide and drug overdose
3 prevention; creating ss. 394.47893 and 394.47894,
4 F.S.; providing legislative intent and purpose;
5 creating the Drug Overdose Death Review Committee and
6 the Suicide Death Review Committee, respectively,
7 within the Department of Health for specified
8 purposes; requiring local public health departments to
9 establish local review committees for a specified
10 purpose; providing for membership of the committees
11 and duties of the Drug Overdose Death Review Committee
12 and the Suicide Death Review Committee, respectively;
13 authorizing external stakeholders to review specified
14 information; providing for stakeholder participation;
15 requiring the Drug Overdose Death Review Committee and
16 the Suicide Death Review Committee, respectively, to
17 annually submit a report to the Department of Health
18 and the Statewide Drug Policy Advisory Council by a
19 specified date; providing requirements for the report;
20 authorizing the chair of the committees to access
21 certain records; authorizing the committees to access
22 certain records and information; authorizing providers
23 to charge a specified fee for records; providing
24 requirements for and prohibitions on the use of such
25 records and information; authorizing the chair of the
26 Drug Overdose Death Review Committee and the Suicide
27 Death Review Committee, respectively, to issue
28 subpoenas for records; providing construction;
29 providing that persons who attend a committee meeting
30 or otherwise participate in committee activities may
31 not be required to testify in any proceeding as to any
32 records or information related to such meetings or
33 activities; providing certain entities and persons
34 immunity from liability for participating in or
35 furnishing records or information to a committee;
36 providing applicability; authorizing the Department of
37 Health, or any political subdivision of the state
38 operating a local review committee, to administer
39 certain funds for the operation of the committees,
40 apply for grants and accept donations, and, to the
41 extent funds are available, hire staff or consultants
42 and reimburse reasonable expenses; authorizing the
43 State Surgeon General or a county or city
44 administrator to substitute certain existing entities
45 for purposes of carrying out the responsibilities of
46 the committees; requiring each regional managing
47 director of the Department of Children and Families to
48 appoint a local review committee representative;
49 providing requirements for the representative;
50 requiring the Department of Health to adopt rules;
51 providing an effective date.
52
53 Be It Enacted by the Legislature of the State of Florida:
54
55 Section 1. Section 394.47893, Florida Statutes, is created
56 to read:
57
394.47893

Drug overdose review; Drug Overdose Death Review

58
Committee; local review committees.—

59
(1)

LEGISLATIVE
INTENT
;
PURPOSE.—It is the intent of the

60
Legislature to establish multidisciplinary, multiagency,

61
epidemiological drug overdose death review committees. The local

62
committees shall review the facts and circumstances of drug

63
related deaths
that
occur within each committee jurisdiction.

64
The local review committees shall work cooperatively. The

65
primary function of the local review committees is to conduct

66
individual case reviews of drug overdose deaths; identify

67
factors contributing to those deaths; make recommendations for

68
system, policy, and practice improvements at the local and state

69
level; promote interagency collaboration and data sharing

70
consistent with federal and state confidentiality protections;

71
and inform prevention initiatives through accurate, timely, and

72
comprehensive data. The purpose of the local review committees

73
is to:

74
(a)

Achieve a greater understanding of the causes and

75
contributing factors of deaths resulting from drug overdose.

76
(b)

Whenever possible, develop a communitywide approach to

77
address the causes and contributing factors.

78
(c)

Identify any gaps, deficiencies, or problems in the

79
delivery of services to individuals by public and private

80
agencies which may be related to deaths that are the result of

81
drug overdose.

82
(d)

Recommend changes in law, rules, and policies at the

83
state and local levels, as well as develop practice standards

84
that support the safe and healthy stabilization of individuals

85
and reduce preventable deaths.

86
(e)

Following internal
review
of identified cases, engage

87
community stakeholders as part of a deidentified review of case

88
findings from the
review
group for broader insights about gaps,

89
deficiencies, or observed themes that identify problems or

90
prevention practices.

91
(f)

Implement such recommendations, to the extent possible.

92
(2)

DRUG OVERDOSE DEATH REVIEW COMMITTEE.—The Drug Overdose

93
Death Review Committee is established within the Department of

94
Health to
review
deaths resulting from drug overdose. Local

95
public health departments shall establish local review

96
committees
,
which shall provide review results to the Drug

97
Overdose Death Review Committee.

98
(a)

Membership
.—

99
1.a.

The Drug Overdose Death Review Committee shall, at a

100
minimum, include representatives appointed by the State Surgeon

101
General from all of the following:

102
(I)

The Department of Health.

103
(II)

County and
city
health and human service
s
departments

104
or divisions.

105
(III)

The medical examiner’s office.

106
(
IV
)

Local managing entities that are contracted by the

107
Department of Children and Families.

108
(V)

Emergency medical services.

109
(
VI
)

Next of kin of persons whose deaths resulted from drug

110
overdose.

111
b.

The members of the Drug Overdose Death Review Committee

112
shall be appointed to staggered terms not to exceed 2 years

113
each, as determined by the State Surgeon General. Members may be

114
appointed to no more than three consecutive terms. The Drug

115
Overdose Death Review Committee shall elect a
chair
from among

116
its members to serve for a 2-year term, and the
chair
may

117
appoint ad hoc committees as necessary to carry out the duties

118
of the committee.

119
2.a.

Local committees may include representatives appointed

120
by county health department directors, to the extent available,

121
from:

122
(
I
)

The Agency for Health Care Administration.

123
(II)

County and
city
health and human service
s
departments

124
or divisions.

125
(III)

Hospitals and health systems.

126
(IV)

Behavioral health service providers and recovery

127
organizations.

128
(V)

Judges and public defenders from the judicial circuit.

129
(VI)

Poison control centers.

130
b.

The members of a local committee shall be appointed to

131
2-year terms and may be reappointed. The local review committee

132
shall elect a
chair
from among its members to serve for a 2-year

133
term. Members shall serve without compensation but may receive

134
reimbursement for per diem and travel expenses incurred in the

135
performance of their duties as provided in s. 112.061 and to the

136
extent that funds are available.

137
(b)

Duties.
—The Drug Overdose Death Review Committee shall:

138
1.

Develop standardized protocols and data collection

139
instruments for use by the local review committees.

140
2.

Review
selected cases for drug overdose death review.

141
3.

Maintain a protected database of reviewed fatalities to

142
safeguard disclosure of private and protected health information

143
and to inventory the cases reviewed. The
chair
and
vice chair
of

144
the review committee shall have access to this protected

145
database. The protected database shall be created by the

146
Department of Health.

147
4.

Study the adequacy of laws, rules, training, and

148
services to determine what changes are needed to decrease the

149
incidence of drug overdose deaths and develop strategies and

150
recruit partners to implement these changes.

151
5.

Promote continuing education for professionals who

152
review
, treat, and prevent deaths related to drug overdose.

153
6.

Recommend, when appropriate,
a
review of the death

154
certificate of any individual who died as a result of drug

155
overdose.

156
7.

Assist the Department of Health in collecting data on

157
deaths that are the result of drug overdose.

158
8.

Submit written reports as requested by the Department of

159
Children and Families. The reports must include:

160
a.

Nonidentifying information from individual cases.

161
b.

Identification of any problems with the data system

162
uncovered during the review process and the committee’s

163
recommendations for system improvements and needed resources,

164
training, and information dissemination, where gaps or

165
deficiencies may exist.

166
c.

All steps taken by the local review committees and

167
private and public agencies to implement necessary changes and

168
improve the coordination of services and reviews.

169
9.

Submit all records requested by the Department of

170
Children and Families at the conclusion of the review of a death

171
resulting from drug overdose.

172
(3)

LOCAL STAKEHOLDER ENGAGEMENT.—Following internal
review

173
by the Drug Overdose Death Review Committee, external

174
stakeholders may review nonidentifiable case findings to

175
generate broader insights into the findings of cases reviewed,

176
to supplement identification of themes
and
problems
,
and
to

177
develop prevention recommendations. Stakeholder participants

178
shall include representatives, to the extent available, from:

179
(a)

The state attorney’s office.

180
(b)

Community-based service agencies.

181
(c)

Persons with lived experience in recovery or loss

182
survivors.

183
(d)

Law enforcement agencies.

184
(e)

Middle schools and high schools.

185
(f)

Physicians.

186
(g)

Social workers.

187
(4)

ANNUAL STATISTICAL REPORT.—The Drug Overdose Death

188
Review Committee shall prepare and submit a comprehensive

189
statistical report by December 1, 2027, and annually thereafter,

190
to the Department of Health and the Statewide Drug Policy

191
Advisory Council
which
includes data, trends, analysis,

192
findings, and recommendations for state and local action

193
regarding
reviewe
d deaths from drug overdose. The data must be

194
presented on an individual calendar year basis and in the

195
context of a multiyear trend. At a minimum, the report must

196
include all of the following:

197
(a)

Descriptive statistics, including demographic

198
information
,
regarding victims and the causes and nature of

199
deaths.

200
(b)

A detailed statistical analysis of the incidence and

201
causes of deaths.

202
(c)

Specific issues identified within current policy,

203
procedure, rule, or statute and recommendations to address those

204
issues from both the state and local committees.

205
(d)

Other recommendations to prevent drug overdose deaths

206
based on an analysis of the data presented in the report.

207
(5)

ACCESS TO AND USE OF RECORDS AND INFORMATION.—

208
(a)

Notwithstanding any other law, the chair of the Drug

209
Overdose Death Review Committee, or the chair of a local review

210
committee, may access any information or records that pertain to

211
an individual whose death is being reviewed by the committee and

212
are necessary for the committee to carry out its duties,

213
including information or records that pertain to a child’s

214
family and all of the following:

215
1.

Patient records in the possession of a public or private

216
provider of medical
care
, dental
care
, substance use treatment,

217
or mental health care, including, but not limited to, a facility

218
licensed under
this chapter,
chapter 393, or chapter 395, or a

219
health care practitioner as defined in s. 456.001. Providers may

220
charge a fee for copies not to exceed 50 cents per page for

221
paper records and $1 per fiche for microfiche records.

222
2.

Information or records of any state or local agency or

223
political subdivision which may assist a committee in reviewing

224
a death, including, but not limited to, information or records

225
of the Department of Children and Families, the Department of

226
Health, the Department of Education, the Department of Juvenile

227
Justice, the Agency for Health Care Administration, or any

228
health facility licensed by this state.

229
(b)

The Drug Overdose Death Review Committee or a local

230
review committee may access all information of a medical

231
examiner or law enforcement agency
which
is not the subject of

232
an active investigation and
which
pertains to the review of
a

233
death. A committee may not disclose any information that is not

234
subject to public disclosure by the law enforcement agency, and

235
active criminal intelligence information or criminal

236
investigative information, as defined in s. 119.011(3), may not

237
be made available for review or access under this section. The

238
committee may not disclose any information or records that

239
contain personally identifiable information of a decedent or

240
family member; health
,
treatment, or social service records; law

241
enforcement or medical examiner records related to the decedent;

242
or information that would identify a provider involved in the

243
care of the decedent.

244
(c)

L
ocal review committees may share with each other any

245
relevant information that pertains to the review of the drug

246
overdose death.

247
(d)

A member of the Drug Overdose Death Review Committee or

248
a local review committee may contact, interview, or obtain

249
information by request from a member of a dece
dent
’s family as

250
part of a committee’s next of kin interview process to inform

251
the review of a death. A member of the dece
dent
’s family may

252
voluntarily provide records or information to the Drug Overdose

253
Death Review Committee or a local review committee.

254
(e)

The chair of the Drug Overdose Death Review Committee

255
may require the production of records by requesting a subpoena,

256
through the Department of Legal Affairs, in any county of the

257
state. Such subpoena is effective throughout the state and may

258
be served by any sheriff. Failure to obey the subpoena is

259
punishable as provided by general law.

260
(f)

This subsection does not authorize the members of any

261
committee to have access to any grand jury proceedings.

262
(g)

A person who has attended a meeting of a committee or

263
who has otherwise participated in activities authorized by this

264
section may not be authorized or required to testify in any

265
civil, criminal, or administrative proceeding as to any records

266
or information produced or presented to a committee during

267
meetings or other activities authorized by this section.

268
However, this paragraph does not prevent any person who presents

269
information to the committee or who is a member of the committee

270
from testifying as to matters otherwise within his or her

271
knowledge. An organization, institution, committee member, or

272
other person who participates or furnishes information, data,

273
reports, or records to a committee is not liable for damages to

274
any person and is not subject to any other civil, criminal, or

275
administrative recourse. This paragraph does not apply to any

276
person who admits to committing a crime.

277
(6)

DEPARTMENT OF HEALTH RESPONSIBILITIES.—

278
(a)

The Department of Health, or any political subdivision

279
of the state operating a local review committee, may administer

280
the funds appropriated to operate the review committees and may

281
apply for grants and accept donations.

282
(b)

To the extent that funds are available, the Department

283
of Health
,
or any political subdivision of the state, may hire

284
staff or consultants to assist a review committee in performing

285
its duties. Funds may also be used to reimburse reasonable

286
expenses of the staff and consultants for the committees.

287
(c)

For the purpose of carrying out the responsibilities

288
assigned to the Drug Overdose Death Review Committee and local

289
review committees, the State Surgeon General or a county or
city

290
administrator may substitute an existing entity whose function

291
and organization includes the function and organization of the

292
committees established under this section.

293
(7)

DEPARTMENT OF CHILDREN AND FAMILIES RESPONSIBILITIES.

294
Each regional managing director of the Department of Children

295
and Families must appoint a local review representative for the

296
region. The representative must have knowledge and expertise in

297
the area of drug overdose. The representative’s general

298
responsibilities include:

299
(a)

Coordinating with the local review committee.

300
(b)

Participati
ng
in the implementation of the drug

301
overdose death review process and all regional activities

302
related to the review of drug overdose deaths.

303
(c)

Working with the Drug Overdose Death Review Committee

304
and the contracted managing entity to ensure that the reviews

305
are thorough and that all issues are appropriately addressed.

306
(d)

Ensuring that all critical issues identified by the

307
local review committee are brought to the attention of the

308
regional managing director and the Secretary of Children and

309
Families.

310
(e)

Providing technical assistance to the Drug Overdose

311
Death Review Committee during the review of any drug overdose

312
death.

313
(8)

RULEMAKING.—The Department of Health shall adopt rules

314
necessary to implement this section.

315 Section 2. Section 394.47894, Florida Statutes, is created
316 to read:
317
394.47894

Suicide review; Suicide Death Review Committee;

318
local review committees.—

319
(1)

LEGISLATIVE
INTENT
;
PURPOSE.—It is the intent of the

320
Legislature to establish multidisciplinary, multiagency,

321
epidemiological suicide death review committees. The local

322
committees shall review the facts and circumstances of suicide

323
deaths
that
occur within each committee jurisdiction. The local

324
review committees shall work cooperatively. The primary function

325
of the local review committees is to conduct individual case

326
reviews of suicide deaths; identify factors contributing to

327
those deaths; make recommendations for system, policy, and

328
practice improvements at the local and state level; promote

329
interagency collaboration and data sharing consistent with

330
federal and state confidentiality protections; and inform

331
prevention initiatives through accurate, timely, and

332
comprehensive data. The purpose of the local review committees

333
is to:

334
(a)

Achieve a greater understanding of the causes and

335
contributing factors of deaths resulting from suicide.

336
(b)

Whenever possible, develop a communitywide approach to

337
address the causes and contributing factors.

338
(c)

Identify any gaps, deficiencies, or problems in the

339
delivery of services to individuals by public and private

340
agencies which may be related to deaths that are the result of

341
suicide.

342
(d)

Recommend changes in law, rules, and policies at the

343
state and local levels, as well as develop practice standards

344
that support the safe and healthy stabilization of individuals

345
and reduce preventable deaths.

346
(e)

Following internal
review
of identified cases, engage

347
community stakeholders as part of a deidentified review of case

348
findings from the
review
group for broader insights about gaps,

349
deficiencies, or observed themes that identify problems or

350
prevention practices.

351
(f)

Implement such recommendations, to the extent possible.

352
(2)

SUICIDE DEATH REVIEW COMMITTEE.—The Suicide Death

353
Review Committee is established within the Department of Health

354
to
review
deaths resulting from suicide. Local public health

355
departments shall establish local review committees
,
which shall

356
provide review results to the Suicide Death Review Committee.

357
(a)

Membership.
—

358
1.a.

The Suicide Death Review Committee shall, at a

359
minimum, include representatives appointed by the State Surgeon

360
General from all of the following:

361
(I)

The Department of Health.

362
(II)

County and
city
health and human service
s
departments

363
or divisions.

364
(III)

The medical examiner’s office.

365
(IV)

Local managing entities that are contracted by the

366
Department of Children and Families.

367
(V)

Emergency medical services.

368
(VI)

Next of kin of persons whose deaths resulted from

369
suicide.

370
b.

The members of the Suicide Death Review Committee shall

371
be appointed to staggered terms not to exceed 2 years each, as

372
determined by the State Surgeon General. Members may be

373
appointed to no more than three consecutive terms. The Suicide

374
Death Review Committee shall elect a
chair
from among its

375
members to serve for a 2-year term, and the
chair
may appoint ad

376
hoc committees as necessary to carry out the duties of the

377
committee.

378
2.a.

Local committees may include representatives appointed

379
by county health department directors, to the extent available,

380
from:

381
(I)

The Agency for Health Care Administration.

382
(II)

County and
city
health and human service
s
departments

383
or divisions.

384
(III)

Hospitals and health systems.

385
(IV)

Behavioral health service providers and recovery

386
organizations.

387
(V)

Judges and public defenders from the judicial circuit.

388
(VI)

Poison control centers.

389
b.

The members of a local committee shall be appointed to

390
2-year terms and may be reappointed. The local review committee

391
shall elect a
chair
from among its members to serve for a 2-year

392
term. Members shall serve without compensation but may receive

393
reimbursement for per diem and travel expenses incurred in the

394
performance of their duties as provided in s. 112.061 and to the

395
extent that funds are available.

396
(b)

Duties.
—The Suicide Death Review Committee shall:

397
1.

Develop standardized protocols and data collection

398
instruments for use by the local review committees.

399
2.

Review
selected cases for
review of deaths from
suicide.

400
3.

Maintain a protected database of reviewed fatalities to

401
safeguard disclosure of private and protected health information

402
and to inventory the cases reviewed. The
c
hair and
v
ice
c
hair of

403
the review committee shall have access to this protected

404
database. The protected database shall be created by the

405
Department of Health.

406
4.

Study the adequacy of laws, rules, training, and

407
services to determine what changes are needed to decrease the

408
incidence of suicide
s
and develop strategies and recruit

409
partners to implement these changes.

410
5.

Promote continuing education for professionals who

411
review
, treat, and prevent deaths related to suicide.

412
6.

Recommend, when appropriate, the review of the death

413
certificate of any individual who died as a result of suicide.

414
7.

Assist the Department of Health in collecting data on

415
deaths that are the result of suicide.

416
8.

Submit written reports as requested by the Department of

417
Health. The reports must include:

418
a.

Nonidentifying information from individual cases.

419
b.

Identification of any problems with the data system

420
uncovered during the review process and the committee’s

421
recommendations for system improvements and needed resources,

422
training, and information dissemination, where gaps or

423
deficiencies may exist.

424
c.

All steps taken by the local review committees and

425
private and public agencies to implement necessary changes and

426
improve the coordination of services and reviews.

427
9.

Submit all records requested by the Department of Health

428
at the conclusion of the review of a death resulting from

429
suicide.

430
(3)

LOCAL STAKEHOLDER ENGAGEMENT.—Following internal
review

431
by the Suicide Death Review Committee, external stakeholders may

432
review nonidentifiable case findings to generate broader

433
insights into the findings of cases reviewed, to supplement

434
identification of themes
and
problems
,
and
to
develop prevention

435
recommendations. Stakeholder participants shall include

436
representatives, to the extent available, from:

437
(a)

The state attorney’s office.

438
(b)

Community-based service agencies.

439
(c)

Persons with lived experience in recovery or loss

440
survivors.

441
(d)

Law enforcement agencies.

442
(e)

Middle schools and high schools.

443
(f)

Physicians.

444
(g)

Social workers.

445
(4)

ANNUAL STATISTICAL REPORT.—The Suicide Death Review

446
Committee shall prepare and submit a comprehensive statistical

447
report by December 1, 2027, and annually thereafter, to the

448
Department of Health and the Department of Children and Families

449
and the Statewide Drug Policy Advisory Council
which
includes

450
data, trends, analysis, findings, and recommendations for state

451
and local action regarding
reviewe
d deaths from suicide. The

452
data must be presented on an individual calendar year basis and

453
in the context of a multiyear trend. At a minimum, the report

454
must include all of the following:

455
(a)

Descriptive statistics, including demographic

456
information
,
regarding victims and the causes and nature of

457
deaths.

458
(b)

A detailed statistical analysis of the incidence and

459
causes of deaths.

460
(c)

Specific issues identified within current policy,

461
procedure, rule, or statute and recommendations to address those

462
issues from both the state and local committees.

463
(d)

Other recommendations to prevent suicide
s
based on an

464
analysis of the data presented in the report.

465
(5)

ACCESS TO AND USE OF RECORDS AND INFORMATION.—

466
(a)

Notwithstanding any other law, the chair of the Suicide

467
Death Review Committee, or the chair of a local review

468
committee, may access any information or records that pertain to

469
an individual whose death is being reviewed by the committee and

470
are necessary for the committee to carry out its duties,

471
including information or records that pertain to a child’s

472
family and all of the following:

473
1.

Patient records in the possession of a public or private

474
provider of medical
care
, dental
care
, substance use treatment,

475
or mental health care, including, but not limited to, a facility

476
licensed under
this chapter,
chapter 393, or chapter 395, or a

477
health care practitioner as defined in s. 456.001. Providers may

478
charge a fee for copies not to exceed 50 cents per page for

479
paper records and $1 per fiche for microfiche records.

480
2.

Information or records of any state or local agency or

481
political subdivision which may assist a committee in reviewing

482
a death, including, but not limited to, information or records

483
of the Department of Children and Families, the Department of

484
Health, the Department of Education, the Department of Juvenile

485
Justice, the Agency for Health Care Administration, or any

486
health facility licensed by this state.

487
(b)

The Suicide Death Review Committee or a local review

488
committee may access all information of a medical examiner or

489
law enforcement agency that is not the subject of an active

490
investigation and that pertains to the review of
a
death. A

491
committee may not disclose any information that is not subject

492
to public disclosure by the law enforcement agency, and active

493
criminal intelligence information or criminal investigative

494
information, as defined in s. 119.011(3), may not be made

495
available for review or access under this section. The committee

496
may not disclose any information or records that contain

497
personally identifiable information of a decedent or family

498
member; health
,
treatment, or social service records; law

499
enforcement or medical examiner records related to the decedent;

500
or information that would identify a provider involved in the

501
care of the decedent.

502
(c)

L
ocal review committees may share with each other any

503
relevant information that pertains to the review of the suicide.

504
(d)

A member of the Suicide Death Review Committee or a

505
local review committee may contact, interview, or obtain

506
information by request from a member of a dece
dent
’s family as

507
part of a committee’s next of kin interview process to inform

508
the review of a death. A member of the dece
dent
’s family may

509
voluntarily provide records or information to the Suicide Death

510
Review Committee or a local review committee.

511
(e)

The
chair
of the Suicide Death Review Committee may

512
require the production of records by requesting a subpoena,

513
through the Department of Legal Affairs, in any county of the

514
state. Such subpoena is effective throughout the state and may

515
be served by any sheriff. Failure to obey the subpoena is

516
punishable as provided by general law.

517
(f)

This subsection does not authorize the members of any

518
committee to have access to any grand jury proceedings.

519
(g)

A person who has attended a meeting of a committee or

520
who has otherwise participated in activities authorized by this

521
section may not be authorized or required to testify in any

522
civil, criminal, or administrative proceeding as to any records

523
or information produced or presented to a committee during

524
meetings or other activities authorized by this section.

525
However, this paragraph does not prevent any person who presents

526
information to the committee or who is a member of the committee

527
from testifying as to matters otherwise within his or her

528
knowledge. An organization, institution, committee member, or

529
other person who participates
in
or furnishes information, data,

530
reports, or records to a committee is not liable for damages to

531
any person and is not subject to any other civil, criminal, or

532
administrative recourse. This paragraph does not apply to any

533
person who admits to committing a crime.

534
(6)

DEPARTMENT OF HEALTH RESPONSIBILITIES.—

535
(a)

The Department of Health, or any political subdivision

536
of the state operating a local review committee, may administer

537
the funds appropriated to operate the review committees and may

538
apply for grants and accept donations.

539
(b)

To the extent that funds are available, the Department

540
of Health or any political subdivision of the state, may hire

541
staff or consultants to assist a review committee in performing

542
its duties. Funds may also be used to reimburse reasonable

543
expenses of the staff and consultants for the committees.

544
(c)

For the purpose of carrying out the responsibilities

545
assigned to the Suicide Death Review Committee and local review

546
committees, the State Surgeon General or a county or
city

547
administrator may substitute an existing entity whose function

548
and organization includes the function and organization of the

549
committees established under this section.

550
(7)

DEPARTMENT OF CHILDREN AND FAMILIES RESPONSIBILITIES.

551
Each regional managing director of the Department of Children

552
and Families
shall
appoint a local review representative for the

553
region. The representative must have knowledge and expertise in

554
the area of suicide. The representative’s general

555
responsibilities include:

556
(a)

Coordinating with the local review committee.

557
(b)

Participat
ing
in the implementation of the suicide

558
death review process and all regional activities related to the

559
review of
deaths from
suicide.

560
(c)

Working with the Suicide Death Review Committee and the

561
contracted managing entity to ensure that the reviews are

562
thorough and that all issues are appropriately addressed.

563
(d)

Ensuring that all critical issues identified by the

564
local review committee are brought to the attention of the

565
regional managing director and the Secretary of Children and

566
Families.

567
(e)

Providing technical assistance to the Suicide Death

568
Review Committee during the review of any suicide death.

569
(8)

RULEMAKING.—The Department of Health shall adopt rules

570
necessary to implement this section.

571 Section 3. This act shall take effect July 1, 2026.